Cargando…
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
BACKGROUND: Erythrocytes are a major source of peripheral α-synuclein (α-Syn). The goal of the current investigation is to evaluate erythrocytic total, oligomeric/aggregated, and phosphorylated α-Syn species as biomarkers of Parkinson’s disease (PD). PD and healthy control blood samples were collect...
Autores principales: | Tian, Chen, Liu, Genliang, Gao, Liyan, Soltys, David, Pan, Catherine, Stewart, Tessandra, Shi, Min, Xie, Zhiying, Liu, Na, Feng, Tao, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521422/ https://www.ncbi.nlm.nih.gov/pubmed/31123587 http://dx.doi.org/10.1186/s40035-019-0155-y |
Ejemplares similares
-
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
por: Sheng, Lifu, et al.
Publicado: (2020) -
Erythrocytic α-Synuclein Species for Parkinson’s Disease Diagnosis and the Correlations With Clinical Characteristics
por: Yu, Zhenwei, et al.
Publicado: (2022) -
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
por: Liu, Xiaodan, et al.
Publicado: (2021) -
Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
por: Yu, Zhenwei, et al.
Publicado: (2023) -
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?
por: Matsumoto, Junichi, et al.
Publicado: (2017)